| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7ad58d3c0b071069a8ee0cb8c8ba2e8 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D407-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
| filingDate |
1996-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97aea1ec409d1eb147c0a454f1d65da0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71ea207c7d63750c9625d7a315062829
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b31316bff09b1fd120947516f2b013aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7cdd35a81b7dcca08b2e8d042e07d132
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84e74a9802faa12bcb4721f4ac313e2c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f06b4d93f4408030e377a44f17f927fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_194b72b8122b3cc8dfd7e08767c3d89f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8112aaa5c4099765301a47b37bc8fac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5bf97dd61307d1f2cc1925026ef54f1 |
| publicationDate |
1996-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2179205-A1 |
| titleOfInvention |
Benzisothiazolyl-substituted aminomethylchromans |
| abstract |
The benzisothiazolyl-substituted aminomethylchromans are prepared either by substituting the corresponding unsubstituted aminomethylchromans on the amine nitrogen or reacting the corresponding benzisothiazolylalkylamines with appropriate activated methylchromans or reacting the amine nitrogen of aminomethylchroman first with an appropriately substituted alkine and then hydrogenating. The benzisothiazolyl-substituted aminomethylchromans can be used as active compounds in medicaments, in particular in medicaments for the treatment of disorders of the central nervous system. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6071860-A |
| priorityDate |
1995-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |